Klaus Orlinger - Apr 19, 2022 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Chief Scientific Officer
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
Stock symbol
HOOK
Transactions as of
Apr 19, 2022
Transactions value $
$0
Form type
4
Date filed
4/20/2022, 04:30 PM
Previous filing
Feb 1, 2022
Next filing
Jul 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $0 +48.4K $0.00 48.4K Apr 19, 2022 Common Stock 48.4K $1.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.